Summary
The effects of the antiestrogens tamoxifen and keoxifene on the bone density of intact and ovariectomized female rats were determined after 4 months of therapy. The antiestrogens did not cause a decrease in bone density in intact animals, although uterine wet weight did decrease. Ovariectomy caused an increase in body weight (25%) and a significant decrease in femur density (P<0.01). Antiestrogens did not further decrease the bone density of ovariectomized rats but rather helped to maintain bone density. Antiestrogens as well as estrogen (oral estradiol benzoate 25µg daily) helped to maintain bone density in the range observed for the intact rats, but inhibited estrogen stimulation of uterine weight. These contrasting pharmacological actions of antiestrogens suggest that patients receiving long-term adjuvant tamoxifen therapy for breast cancer should be evaluated to determine whether tamoxifen can retard the development of osteoporosis.
Article PDF
Avoid common mistakes on your manuscript.
References
Furr BJ, Jordan VC: The pharmacology and clinical uses of tamoxifen. Pharmacol Ther 25: 127–205, 1984
Legha SS, Carter SK: Antiestrogens in the treatment of breast cancer. Cancer Treat Rev 3: 205–215, 1976
Fisher B, Redmond C, Brown A, Wolmark N, Wittliff J, Fisher ER, Plotkin D, Bowman D, Sachs S, Wolter J, Frelick R, Desser R: Treatment of primary breast cancer with chemotherapy and tamoxifen. N Engl J Med 305: 1–6, 1981
Baum M, and other members of the Nolvadex Adjuvant Trial Organization: Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. Lancet i: 836–840, 1985
Cummings FJ, Gay R, Davis TE, Tormey DC, Harris JE, Falkson G, Arseneau J: Adjuvant tamoxifen treatment of eldery women with stage II breast cancer. A double-blind comparison with placebo. Annals Int Med 103: 324–329, 1985
Tormey DC, Jordan VC: Long-term adjuvant therapy in node positive breast cancer. A metabolic and pilot clinical study. Breast Cancer Res Treat 4: 297–302, 1984
Tormey DC, Rasmussen P, Jordan VC: Update on longterm tamoxifen study. Breast Cancer Res Treat 9: 157–158, 1987
Jordan VC: Tamoxifen prophylaxis: prevention is better than cure — prevention is cure? In: Cavalli F (ed) Endocrine Therapy of Breast Cancer: Concepts and Strategies. European School of Oncology Monograph, 1986, pp 117–120
Lindsay R, Hart DM, Forrest C, Baird C: Prevention of spinal osteoporosis in oophorectomized women. Lancet ii: 1151–1153, 1980
Beall PT, Misra KL, Young RL, Spjut HJ, Evan HJ, LeBlanc A: Clomiphene protects against osteoporosis in the mature ovariectomized rat. Calcif Tissue Int 36: 123–125, 1985
Clark JH, Markaverich BN: The agonist-antagonistic properties of clomiphene: a review. Pharmacol Ther 15: 467–519, 1982
Black LJ, Jones CD, Falcone JF: Antagonism of estrogen action with a new benzothiophene-derived antiestrogen. Life Sci 32: 1031–1036, 1983
Gottardis MM, Jordan VC: The antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model. Cancer Res 47: 4020–4024, 1987
Suda T, DeLuca HF, Tanaka Y: Biological activity of 25-hydroxyergocalciferol in rats. J Nutr 100: 1049–1052, 1970
Saville PD: Changes in skeletal mass and fragility with castration in the rat: a model of osteoporosis. J Am Geriatr Soc 17: 155–166, 1969
Lingren JU, Lindholm TS: Effect of 1-alpha-hydroxy vitamin D3 on osteoporosis in rats induced by oophorectomy. Calcif Tissue Int 27: 161–164, 1979
Wade GN, Zucker I: Development of hormonal control over food intake and body weight in female rats. J Comp Phys Psychol 70: 213–220, 1970
Jordan VC, Dowse LJ: Tamoxifen as an antitumor agent: effect on oestrogen binding. J Endocrinol 68: 247–303, 1976
Aitken JM, Armstrong E, Anderson JB: Osteoporosis after oophorectomy in the mature female rat and the effect of estrogen and/or progestogen replacement therapy in its prevention. J Endocrinol 55: 79–87, 1972
Gusberg S: Hormone dependence of endometrial cancer. Obstet Gynecol 30: 287–293, 1967
Swenerton KD: Treatment of advanced endometrial carcinoma with tamoxifen. Cancer Treat Rep 64: 805–808, 1980
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jordan, V.C., Phelps, E. & Lindgren, J.U. Effects of anti-estrogens on bone in castrated and intact female rats. Breast Cancer Res Tr 10, 31–35 (1987). https://doi.org/10.1007/BF01806132
Issue Date:
DOI: https://doi.org/10.1007/BF01806132